Dongwha Pharm.Co.,Ltd (KRX:000020)
6,390.00
+50.00 (0.79%)
At close: Dec 19, 2025
Dongwha Pharm.Co.,Ltd Market Cap
Dongwha Pharm.Co.,Ltd has a market cap or net worth of 177.12 billion as of December 19, 2025. Its market cap has decreased by -3.18% in one year.
Market Cap
177.12B
Enterprise Value
300.79B
Revenue
493.33B
Ranking
n/a
PE Ratio
23.35
Stock Price
6,390.00
Market Cap Chart
Since August 28, 1995, Dongwha Pharm.Co.,Ltd's market cap has increased from 72.32B to 177.12B, an increase of 144.89%. That is a compound annual growth rate of 3.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 177.12B | 1.43% |
| Dec 30, 2024 | 174.62B | -38.57% |
| Dec 28, 2023 | 284.26B | 10.91% |
| Dec 29, 2022 | 256.31B | -36.58% |
| Dec 30, 2021 | 404.12B | -25.51% |
| Dec 30, 2020 | 542.49B | 136.46% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 82.86T |
| Celltrion | 40.61T |
| ALTEOGEN | 22.65T |
| ABL Bio | 10.50T |
| SK Biopharmaceuticals | 10.35T |
| Yuhan | 8.59T |
| LigaChem Biosciences | 6.27T |
| Peptron | 6.18T |